+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Memantine"

From
From
From
From
From
From
From
From
From
From
From
Alzheimer Disease Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Alzheimer Disease Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 111 Pages
  • China
From
Disease Analysis: Alzheimer's Disease - Product Thumbnail Image

Disease Analysis: Alzheimer's Disease

  • Report
  • June 2021
  • 87 Pages
  • Global
Alzheimer's Disease Market and Forecast Analysis 2034 - Product Thumbnail Image

Alzheimer's Disease Market and Forecast Analysis 2034

  • Drug Pipelines
  • February 2019
  • 300 Pages
  • Global
From
Alzheimer Disease Drugs Markets in China - Product Thumbnail Image

Alzheimer Disease Drugs Markets in China

  • Report
  • March 2025
  • 239 Pages
  • China
From
Loading Indicator

Memantine is a drug used to treat symptoms of Alzheimer's disease and other forms of dementia. It is classified as an NMDA receptor antagonist, which works by blocking the action of a neurotransmitter called glutamate. This helps to reduce the symptoms of dementia, such as memory loss, confusion, and difficulty with language. Memantine is also used to treat Parkinson's disease, Huntington's disease, and multiple sclerosis. Memantine is a relatively new drug, having been approved by the FDA in 2003. It is available in both oral and intravenous forms, and is typically prescribed in combination with other drugs. It is generally well-tolerated, with few side effects. The memantine market is a growing one, with a number of companies offering products. These include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Other companies, such as Actavis, Lupin, and Dr. Reddy's Laboratories, also offer generic versions of the drug. Show Less Read more